Recombinant Human Phosphodiesterase 4A/PDE4A Protein, CF

R&D Systems | Catalog # 7767-PE

R&D Systems
Loading...

Key Product Details

  • R&D Systems Sf 21 (baculovirus)-derived Recombinant Human Phosphodiesterase 4A/PDE4A Protein (7767-PE)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

Sf 21 (baculovirus)

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Spodoptera frugiperda, Sf 21 (baculovirus)-derived human Phosphodiesterase 4A/PDE4A protein
Pro331-Met723, with an N-terminal Met and a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.

Endotoxin Level

<0.01 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Pro331

Predicted Molecular Mass

46 kDa

SDS-PAGE

44-48 kDa, reducing conditions

Activity

Measured by its ability to convert cAMP to 5'-AMP.
The specific activity is >28,000 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation, and Storage

7767-PE
Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Background: Phosphodiesterase 4A/PDE4A

Cyclic nucleotide phosphodiesterases (PDEs) regulate the intracellular concentration of the second messengers, cAMP and cGMP (1-3). Phosphodiesterase 4, subtype A (PDE4A) is a rolipram-sensitive member of the cyclic phosphodiesterase family and catalyzes the specific hydrolysis of cAMP to 5'-AMP. Numerous inhibitors of PDE4 have been studied and considered as anti-inflammatory therapeutics for treatment of asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type 2 diabetes, and potentially several CNS disorders (1-5). R&D Systems’ recombinant human PDE4A corresponds to the catalytic domain (6).

References

  1. Bender A.T. and J.A. Beavo (2006) Pharmacol. Rev. 58:488.
  2. Menniti F.S. et al. (2006) Nat. Rev. Drug Discov. 5:660.
  3. Omori K. and J. Kotera (2007) Circ. Res. 100:309.
  4. Spina D. (2008) Br. J. Pharmacol. 155:308.
  5. Wang, H. et al. (2007) Biochem. J. 408:193.
  6. Lario, P.I. et al. (2001) Arch. Biochem. Biophys. 394:54.

Alternate Names

DPDE2, PDE46, PDE4A

Entrez Gene IDs

5141 (Human); 18577 (Mouse); 25638 (Rat)

Gene Symbol

PDE4A

UniProt

Additional Phosphodiesterase 4A/PDE4A Products

Product Documents for Recombinant Human Phosphodiesterase 4A/PDE4A Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Phosphodiesterase 4A/PDE4A Protein, CF

Coomassie is a registered trademark of Imperial Chemical Industries Ltd.

For research use only

Customer Reviews for Recombinant Human Phosphodiesterase 4A/PDE4A Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Phosphodiesterase 4A/PDE4A Protein, CF and earn rewards!

Have you used Recombinant Human Phosphodiesterase 4A/PDE4A Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Phosphodiesterase 4A/PDE4A Protein, CF (7767-PE):

Materials
  • Assay Buffer (1X): 20 mM Tris, 1 mM MgCl2, 1 mM DTT, 0.01538% CHAPS, pH 7.5
  • Recombinant Human Phosphodiesterase 4A/PDE4A (rhPDE4A) (Catalog # 7767-PE)
  • Adenosine 3’,5’-cyclic monophosphate (cAMP) (Sigma, Catalog # A6885) 0.1 M stock in deionized water
  • Sialyltransferase Activity Kit (Catalog # EA002)
  • 96-well Clear Plate (Costar, Catalog # 92592)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Dilute 1 mM Phosphate Standard provided by the Sialyltransferase Kit by adding 40 µL of the 1 mM Phosphate Standard to 360 µL of Assay Buffer for a 100 µM stock.
  2. Continue standard curve by performing six additional one‑half serial dilutions of the 100 µM Phosphate stock in Assay Buffer. The standard curve has a range of 0.039‑2.5 nmol per well due to volume loaded in step 5.
  3. Dilute rhPDE4A to 0.025 µg/mL in Assay Buffer.
  4. Create a substrate mixture containing 1 µg/mL Coupling Phosphatase 2 and 0.4 mM cAMP in Assay Buffer.
  5. Load 25 µL of each dilution of the standard curve into a plate. Include a Control containing 25 µL of Assay Buffer.
  6. Load 25 µL of the 0.025 µg/mL rhPDE4A into the plate.
  7. Add 25 µL of the substrate mixture to all wells, including the standard curve.
  8. Cover the plate with a plate sealer and incubate at 37 °C for 30 minutes.
  9. Add 30 µL of the Malachite Green Reagent A to all wells. Mix briefly.
  10. Add 100 µL of deionized water to all wells, including curve. Mix briefly.
  11. Add 30 µL of the Malachite Green Reagent B to all wells. Mix and incubate for 20 minutes at room temperature.
  12. Read plate at 620 nm (absorbance) in endpoint mode.
  13. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Phosphate released* (nmol) x (1000 pmol/nmol)
Incubation time (min) x amount of enzyme (µg)

     *Derived from the phosphate standard curve using linear or 4-parameter fitting and adjusted for Control.

Per Reaction:

  • rhPDE4A: 0.000625 μg
  • Coupling Phosphatase 2: 25 ng
  • cAMP: 0.2 mM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes
Loading...